3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
26
Small Cell Lung Carcinoma
22
Neuroblastoma
12
Fallopian Tube Neoplasms
12
Uterine Cervical Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Lung Neoplasms
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
4
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Brain Neoplasms
3
Sarcoma
2
Recurrence
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Small Cell
2
Carcinoma, Neuroendocrine
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Retinoblastoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Interventions
pembrolizumab
37
Paclitaxel
36
Carboplatin
31
Cyclophosphamide
22
Albumin-Bound Paclitaxel
20
atezolizumab
16
130-nm albumin-bound paclitaxel
16
Taxes
15
Doxorubicin
15
Cisplatin
13
Capecitabine
13
Nivolumab
10
Docetaxel
8
olaparib
7
Gemcitabine
6
Everolimus
6
talazoparib
5
durvalumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Bevacizumab
5
veliparib
4
spartalizumab
4
sacituzumab govitecan
4
pegfilgrastim
4
liposomal doxorubicin
4
eribulin
4
Specimen Handling
4
Immunoglobulin G
4
trilaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
Topotecan
×
Clear all
No trials found.